SANA
SANA
NASDAQ · Biotechnology

Sana Biotechnology Inc

$3.10
+0.00 (+0.00%)
As of Sep 20, 10:15 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 13 87%
Hold 2 13%
Sell 0 0%
Price Target
Analyst Price Target +1,192.9% upside
Low Target $23.55
Average Target $40.08
High Target $57.48
Current Price $3.10
Current
$3.10
Target
$40.08
$23.55 $40.08 avg $57.48
Scenario Analysis
Bear Case
$23.55
659.7%
Low target
Base Case
$40.08
+1,192.9%
Avg target
Bull Case
$57.48
+1,754.2%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$6.55
-52.7% from high
52-Week Low
$2.61
+18.8% from low
Target vs 52W High
$40.08
+511.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.6%
AMGN
Amgen Inc
Hold 43 47% $190.87 -51.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +140.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.2%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -13.6%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -61.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%